PCS
VRNA

Personal CFO Solutions’s Verona Pharma VRNA Stock Holding History

Personal CFO Solutions’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,495
Closed -$614K – 530
2025
Q2 		$614K Buy
6,495
+439
+7% +$32.5K 0.11% 189
2025
Q1 		$384K Sell
6,056
-53
-0.9% -$3.17K 0.08% 257
2024
Q4 		$284K Buy
+6,109
New +$229K 0.06% 341
2021
Q2 		– Sell
-10,000
Closed -$84K – 469
2021
Q1 		$84K Buy
+10,000
New +$83K 0.02% 395

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Personal CFO Solutions's VRNA Position: Q3 2025 in Review

Personal CFO Solutions sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 6,495 shares — an estimated $614K sold.

Personal CFO Solutions first reported a position in VRNA in Q1 2021 and held it in 4 quarters. The position peaked at $614K in Q2 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • Personal CFO Solutions reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • Personal CFO Solutions sold 6,495 Verona Pharma shares in Q3 2025, an estimated $614K.
  • Personal CFO Solutions first reported a position in Verona Pharma in Q1 2021 and held it in 4 quarters.
  • Personal CFO Solutions's Verona Pharma position peaked at $614K in Q2 2025.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on Personal CFO Solutions's 13F filing for Q3 2025, filed 10 Nov 2025.